Return to search

BioTheryX scoops up $35m Series D

BioTheryX Inc, a biotechnology company focused on treating difficult diseases, has raised $35 million in Series D financing.

BioTheryX Inc, a biotechnology company focused on treating difficult diseases, has raised $35 million in Series D financing. MSD Partners LP led the round. Raymond James’ Alex Brown division was the placement agent for the financing.

Source: Press Release